← Open Payments lookup

ARCHANA TRIVEDI: Open Payments

NPI 1104068261 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,587 in 111 payments from 16 companies in 2025. Trend: 2023 $1,982 · 2024 $2,018 · 2025 $2,587

Food & beverage: $2,587
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.16$354
Teva Pharmaceuticals USA, Inc.9$321
Otsuka America Pharmaceutical, Inc.11$293
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$256
Axsome Therapeutics, Inc.11$236
ABBVIE INC.16$197
Bausch Health US, LLC9$195
Supernus Pharmaceuticals, Inc.13$186
Lundbeck LLC8$180
E.R. Squibb & Sons, L.L.C.1$123

Products named: REXULTI, INGREZZA, CAPLYTA, Auvelity, VRAYLAR, APLENZIN, AUSTEDO XR, Qelbree.

Industry payments across CA — which companies pay providers there.